Vizuri Health Sciences LLC
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2017–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Vizuri ranks #43,977 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.
- #43,977
- of 49,997 US assignees by volume
- 31st percentile
- by Innovation Score (29.6/100)
- 48.3
- avg claims per patent
- -80%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R43977 · US Corporation #43,977 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #43,977/49,997
- PHOTO-FINISH VIT
- CPC-NARROW A61P · 5 areas
- INNOV-THIN 29.6/100
- CLAIMS-DENSE 48.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -80% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: VIT (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Vizuri’s 29.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Vizuri
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Vizuri Health Sciences · this assignee 30
Vizuri Health Sciences · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Vizuri's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Vizuri?
Each dot is one of Vizuri’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vizuri’s own 48.3 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Vizuri's grants concentrate
Vizuri Health Sciences LLC is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2017. By volume, Vizuri sits between VIT and Voipfuture GMBH.
Who files at Vizuri's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- VIT
VIT
6 patents
- Vital Alert Commu…
Vital Alert Communication Inc.
6 patents
- Vital Signs
Vital Signs, Inc.
6 patents
- Vitalmex Internac…
Vitalmex Internacional S.A. DE C.V.
6 patents
- Vmas Solutions
Vmas Solutions, Inc.
6 patents
- VME Process
VME Process, Inc.
6 patents
- VOF Hortipartners
VOF Hortipartners
6 patents
- Voipfuture
Voipfuture GMBH
6 patents
- Vizuri Health Sci… ◀
Vizuri Health Sciences LLC
6 patents
What this shows Vizuri holds 6 patents at rank #43,896, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Vizuri
By rank, the assignees closest to #43,896 in granted patent volume.
- VIT #43,892 · 6 patents
- Vital Alert Communication Inc. #43,893 · 6 patents
- Vital Signs, Inc. #43,894 · 6 patents
- Vitalmex Internacional S.A. DE C.V. #43,895 · 6 patents
- Vmas Solutions, Inc. #43,897 · 6 patents
- VME Process, Inc. #43,898 · 6 patents
- VOF Hortipartners #43,899 · 6 patents
- Voipfuture GMBH #43,900 · 6 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Vizuri's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Vizuri's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 31st percentile higher than 31% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 16.7% |
| 2018 | 3 | 50.0% |
| 2019 | 1 | 16.7% |
| 2020 | 1 | 16.7% |
Which technologies does Vizuri Health Sciences LLC patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Vizuri Health Sciences LLC's patent record in context - here's where to go next.
- Vizuri Health Sciences LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #43,977 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Vizuri Health Sciences LLC against VIT, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.